Subcutaneous RS4;11 Human acute lymphoblastic leukemia Xenograft Model
Cell information:
RS4;11 cells are human acute lymphoblastic leukemia cells and can be used for PI3Kδ inhibitor screening. Click for more information (https://depmap.org/portal/cell_line/ACH-000874?tab=mutation).
Model information:
Subcutaneously inoculated in NOD/SCID mice and matrigel is required for tumor formation. Usually grouping at about 18 days after inoculation, and treatment time window after grouping is about 22 days.


Integrate Drug Discovery Service
Copyright yourname allrights reserved All rights reserved:Suzhou Truway Biotechnology Inc.